NCT05920954

Brief Summary

Acute Cholangitis is an emergency associated with significant morbidity and mortality which require prompt recognition and treatment. The decompression of biliary tree along with antibiotics are mainstay of therapy. Randomized comparative studies showed that ERCP achieves biliary decompression with markedly less morbidity and mortality compared with surgery, regardless of clinical drainage. Percutaneous trans hepatic drainage (PTBD) can be alternative to endoscopic drainage in selected group especially advanced hilar strictures and patients who are unfit for endoscopic procedure. Recent ASGE guidelines suggested the performance of ERCP within 48 hours for patients with acute cholangitis; however it is conditional recommendation with very low quality of evidence. Till date, no randomized trial has compared urgent ERCP versus early ERCP for acute cholangitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
304

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 27, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

June 30, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2024

Completed
Last Updated

October 2, 2025

Status Verified

July 1, 2023

Enrollment Period

12 months

First QC Date

May 23, 2023

Last Update Submit

September 27, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • ERCP performed within 24 hours of hospitalization versus ERCP performed between 24 to 48 hours of hospitalization

    To perform a single-centre, randomized trial comparing the efficacy (the ability to produce a desired or intended result) of urgent versus early ERCP (Endoscopic retrograde cholangiopancreatography) for reducing the risk of 30 days of mortality.

    Two Years

  • ERCP performed within 24 hours of hospitalization versus ERCP performed between 24 to 48 hours of hospitalization

    PRIMARY OUTCOME: 30 day mortality

    Two Years

Secondary Outcomes (1)

  • ERCP performed within 24 hours of hospitalization versus ERCP performed between 24 to 48 hours of hospitalization

    Two Years

Study Arms (2)

Urgent ERCP

EXPERIMENTAL

Urgent ERCP (\<24 Hours).

Procedure: ERCP

Early ERCP

EXPERIMENTAL

Early ERCP(24 to 48 Hours).

Procedure: ERCP

Interventions

ERCPPROCEDURE

Repeat ERCP

Early ERCPUrgent ERCP

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who met criteria for a definite diagnosis acute cholangitis.

You may not qualify if:

  • Patients with severe acute cholangitis at admission.
  • Age \< 18 years.
  • Pregnancy.
  • Associated Acute Severe Pancreatitis.
  • Patients with suspected high grade (Bismuth III/IV) biliary stricture in whom PTBD is considered as primary method of biliary drainage.
  • Not giving consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AIG Hospitals

Hyderabad, Telangana, 500032, India

Location

MeSH Terms

Interventions

Cholangiopancreatography, Endoscopic Retrograde

Intervention Hierarchy (Ancestors)

CholangiographyRadiography, AbdominalRadiographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, Digestive SystemEndoscopy, Digestive SystemEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2023

First Posted

June 27, 2023

Study Start

June 30, 2023

Primary Completion

June 10, 2024

Study Completion

July 10, 2024

Last Updated

October 2, 2025

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations